NORIS, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.654
AS - Asia 5.524
EU - Europa 4.241
SA - Sud America 680
AF - Africa 147
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
Totale 17.275
Nazione #
US - Stati Uniti d'America 6.498
CN - Cina 2.804
SG - Singapore 1.156
IE - Irlanda 965
HK - Hong Kong 582
FI - Finlandia 514
BR - Brasile 499
DE - Germania 498
UA - Ucraina 485
VN - Vietnam 464
IT - Italia 396
RU - Federazione Russa 395
SE - Svezia 306
FR - Francia 253
GB - Regno Unito 204
IN - India 125
CA - Canada 92
AR - Argentina 84
ZA - Sudafrica 70
BD - Bangladesh 66
IQ - Iraq 53
JP - Giappone 36
MX - Messico 34
NL - Olanda 32
EC - Ecuador 30
PL - Polonia 30
TR - Turchia 30
PK - Pakistan 26
ES - Italia 24
ID - Indonesia 24
SA - Arabia Saudita 24
UZ - Uzbekistan 21
BE - Belgio 20
AU - Australia 18
CO - Colombia 18
PH - Filippine 18
RO - Romania 17
MA - Marocco 16
CZ - Repubblica Ceca 15
AT - Austria 13
EG - Egitto 12
IR - Iran 11
AZ - Azerbaigian 10
JO - Giordania 10
KE - Kenya 10
PE - Perù 10
VE - Venezuela 10
ET - Etiopia 9
EU - Europa 9
GR - Grecia 9
LT - Lituania 9
PY - Paraguay 9
AL - Albania 8
CH - Svizzera 8
CL - Cile 8
MY - Malesia 8
PA - Panama 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
UY - Uruguay 7
KG - Kirghizistan 6
NP - Nepal 6
DZ - Algeria 5
HU - Ungheria 5
KR - Corea 5
KZ - Kazakistan 5
LB - Libano 5
MU - Mauritius 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
IL - Israele 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
DK - Danimarca 3
HN - Honduras 3
JM - Giamaica 3
LU - Lussemburgo 3
MD - Moldavia 3
RS - Serbia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
DM - Dominica 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 17.257
Città #
Dublin 965
Chandler 874
San Jose 672
Jacksonville 662
Singapore 645
Nanjing 615
Ashburn 572
Hong Kong 565
Dallas 520
Beijing 426
Boardman 279
Nanchang 224
Princeton 194
Shenyang 184
Wilmington 181
Lawrence 180
Medford 178
Munich 176
Changsha 165
Hebei 165
Lauterbourg 165
Ho Chi Minh City 160
Helsinki 156
Los Angeles 149
Jiaxing 128
Hanoi 125
Tianjin 96
New York 93
Hangzhou 91
Ann Arbor 89
Milan 86
Buffalo 74
Pavia 65
Shanghai 64
São Paulo 63
Johannesburg 57
Moscow 56
Redondo Beach 53
Houston 48
Woodbridge 47
Orem 43
Turku 43
Council Bluffs 37
Chennai 35
Toronto 35
Guangzhou 33
Tokyo 33
Verona 32
Montreal 29
Fairfield 28
The Dalles 28
Da Nang 27
Santa Clara 26
Seattle 26
Denver 25
Frankfurt am Main 25
Norwalk 25
Brooklyn 24
London 24
Warsaw 21
Pune 20
Belo Horizonte 19
San Francisco 19
Zhengzhou 19
Ankara 18
Atlanta 18
Baghdad 18
Brussels 18
Phoenix 18
Tashkent 18
Brasília 17
Chicago 17
Falkenstein 17
Manchester 17
Haiphong 16
Jinan 16
Mexico City 16
Rome 16
Des Moines 15
Rio de Janeiro 15
Stockholm 15
Columbus 14
Brno 13
Falls Church 12
Nuremberg 12
Timisoara 12
Auburn Hills 11
Mumbai 11
Quito 11
Secaucus 11
Amsterdam 10
Biên Hòa 10
Buenos Aires 10
Dhaka 10
Paris 10
Sydney 10
Amman 9
Boston 9
Fuzhou 9
Jeddah 9
Totale 11.471
Nome #
Anemia in patients with Covid-19: pathogenesis and clinical significance 286
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 163
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 161
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 160
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 153
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 147
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 146
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 140
Antigeni minori di istocompatibilità 139
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 138
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 137
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 137
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 136
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 136
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders 131
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 131
A HOMOZYGOUS POINT MUTATION IN A LEUCINE-RICH MOTIF OF PLATELET GLYCOPROTEIN-IX ASSOCIATED WITH BERNARD-SOULIER SYNDROME (BSS) 129
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 129
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 125
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 124
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 123
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 119
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 118
Spectrum of the mutations in Bernard-Soulier syndrome. 117
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 117
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 117
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 117
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 117
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 115
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 115
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 115
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 115
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 115
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 115
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 114
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 114
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 114
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 114
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 113
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 113
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 111
A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. 111
Inherited thrombocytopenias. The evolving spectrum. 111
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 110
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 110
Platelet-independent defect in hemostasis associated with sirolimus use 109
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 107
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 107
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk disorders. In patients the SPATA-DVT with inherited Study platelet 106
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 104
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 104
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 103
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 103
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 103
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 102
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 102
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 102
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 102
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 101
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 101
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 99
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 99
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 98
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 98
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 98
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 97
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 97
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 97
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 96
Inherited thrombocytopenias in the era of personalized medicine 95
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NATP) CAUSED BY A NEW LOW-FREQUENCY PLATELET-SPECIFIC ALLOANTIGEN, MAXA, LOCATED ON GPIIB 95
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 95
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 94
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 94
In vitro and in vivo effects of desmopressin on platelet function 94
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 93
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 93
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 93
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 92
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 92
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 92
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 91
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 91
Platelet count and aging 90
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 90
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 90
ANKRD26-related thrombocytopenia and myeloid malignancies 90
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 90
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 89
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function 89
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 89
A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders 89
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 88
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 88
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 88
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 88
Effetto del Diltiazem sulla funzionalità piastrinica ex vivo 86
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 85
Totale 11.207
Categoria #
all - tutte 72.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021326 0 0 0 0 0 0 0 0 0 152 138 36
2021/2022913 24 1 32 17 36 48 14 53 53 35 108 492
2022/20232.615 273 158 15 232 265 271 5 138 1.122 21 67 48
2023/2024890 113 125 33 82 107 240 19 58 11 39 37 26
2024/20252.556 48 230 53 84 52 178 141 201 534 89 321 625
2025/20265.958 499 432 827 731 716 305 1.296 287 524 341 0 0
Totale 17.702